Electrosurgical balloons

Information

  • Patent Grant
  • 9750565
  • Patent Number
    9,750,565
  • Date Filed
    Friday, September 30, 2011
    13 years ago
  • Date Issued
    Tuesday, September 5, 2017
    7 years ago
Abstract
An electrosurgical balloon includes an inflatable balloon body formed of a non-conductive substrate material. One or more electrodes are disposed on an exterior surface of the balloon body. The electrodes can include a pair of bipolar electrodes, and the balloon body can have at least one fluid outlet hole configured to provide fluid to the pair of bipolar electrodes. A second inflatable balloon body can be disposed inside the first inflatable balloon body. The electrosurgical balloon can be incorporated into a catheter assembly, in which the electrosurgical balloon is a balloon electrode tip at a distal end of a catheter.
Description
BACKGROUND OF THE INVENTION

Field of the Invention


The present invention relates to medical devices, particularly to an electrosurgical balloon having one or more electrodes disposed on an exterior surface of the balloon, and a bipolar electrode configuration in which a pair of bipolar electrodes are disposed on an exterior surface of the balloon.


Background Art


Medicine is providing ever-increasing demands for devices that can navigate narrow passageways to a desired location within a body so that diagnostic and therapeutic procedures can be performed at that location. Currently, elongated medical devices such as catheters can extend into a body from outside via an access point through various connected passageways to a target location. It is sometimes desirable to perform electrosurgical procedures at the target location.


An electrosurgical procedure involves a medical device having an electrode tip that is electrically energized to perform a procedure such as coagulation, dissection, desiccation and cautery. The electrical energy can be provided in either direct current (DC) form or in alternating current (AC) form. Low frequency electrical energy, including DC, can stimulate muscle and nerves and have potentially undesirable outcomes, such as cardiac arrest, if not properly handled. Higher frequency electrical energy, and in particular electrical energy in the radiofrequency (RF) range (e.g., about 3 kilohertz to about 300 gigahertz), may not stimulate muscle or nerves, and therefore may be better suited to core and coagulate tissue. An electrode tip energized by ultrasonic energy can also be used to perform electrosurgical procedures such as coagulation and tissue ablation.


Modern day elongated medical devices can provide percutaneous access to inner organs and other tissue, and can allow clinicians to navigate to remote and narrow locations within a body. To provide such percutaneous access, these elongated medical devices must meet a variety of requirements such as a desired length, a sufficiently small outer diameter to permit navigation to narrow body passageways, and sufficiently large inner diameter to permit delivery of the required functionality to the remote location. In the case of an elongated medical device having an RF-powered electrode tip, for example, the device can have an inner diameter sufficiently large to transfer the required energy to the electrode tip. To guide the electrode tip to the target site within a body, the elongated medical device including the electrode tip can be deployed into the body through a small trocar. The elongated medical device is advanced in the body to the target site in the body, and the electrode tip is energized at the target site to perform the electrosurgical procedure. An elongated delivery system (e.g., a delivery catheter and/or guidewire) can be used to guide the elongated medical device through the body to the target site.


Electrode tips delivering RF energy can be monopolar or bipolar. A monopolar tip includes one electrode, and a ground pad electrode is located on the patient. Energy applied through the electrode travels through the patient to ground, typically the ground pad. With a bipolar tip, the ground pad electrode located on the patient is eliminated and replaced with a second electrode pole as part of the tip. These active and return electrodes of a bipolar tip are typically positioned close together to ensure that, upon application of electrical energy, current flows directly from the active to the return electrode. Bipolar tips can be advantageous compared to monopolar tips because the return current path only minimally flows through the patient. In bipolar tips, both the active and return electrode are typically exposed so they may both contact tissue, thereby providing a return current path from the active to the return electrode through the tissue. Also, the depth of tissue penetration may be advantageously less with a bipolar tip than with a monopolar tip. Whether monopolar or bipolar, electrode tips made of rigid materials govern the size and shape of the electrode tip that can be deployed through a small trocar and through narrow passageways in the body. The size and shape of the electrode tip can affect the functionality and performance capabilities of the electrode tip at a remote surgical site in the body.


BRIEF SUMMARY

What is needed is an electrode tip that can have a size and shape to achieve desired functionality and performance capabilities at a surgical site, with minimal or no size restrictions arising from the diameter of the elongated medical device, the trocar, and/or the delivery catheter. The present invention satisfies the above needs and provides further related advantages as will be made apparent by the description of the embodiments that follow.


Electrosurgical balloons and catheter assemblies employing electrosurgical balloons as electrode tips are presented. In some embodiments, an electrosurgical balloon includes an inflatable balloon body formed of a non-conductive substrate material, a pair of bipolar electrodes disposed on an exterior surface of the balloon body, and at least one fluid outlet hole in the balloon body. The fluid outlet hole can be configured to provide a conductive fluid from a fluid source to the pair of bipolar electrodes. The pair of bipolar electrodes include a first electrode and a second electrode in a bipolar electrode configuration.


In some embodiments, a catheter assembly includes a catheter and a balloon electrode tip. The catheter includes an elongated body having a distal end portion to which the balloon electrode tip is attached. The balloon electrode tip includes an inflatable balloon body formed of a non-conductive substrate material, a pair of bipolar electrodes disposed on an exterior surface of the balloon body, and at least one fluid outlet hole in the balloon body configured to provide a fluid from a fluid source to the pair of bipolar electrodes.


In some embodiments, a catheter assembly includes a first catheter, a second catheter, and a balloon electrode tip. The first catheter includes a first elongated body having a first distal end portion, and the second catheter includes a second elongated body having a second distal end portion and a lumen. The first catheter is disposed within the lumen. The balloon electrode tip is attached to the first distal end portion, and includes an outer inflatable balloon body formed of a non-conductive substrate material, an inner inflatable balloon body disposed inside the outer inflatable balloon body, and an electrode disposed on an exterior surface of the outer balloon body.


Methods of using a balloon electrode tip to treat tissue are also presented.





BRIEF DESCRIPTION OF THE DRAWINGS/FIGURES

The accompanying drawings, which are incorporated herein and form a part of the specification, illustrate the present invention and, together with the description, further serve to explain the principles of the invention and to enable a person skilled in the pertinent art to make and use the invention. In the drawings, like reference numbers, letters, or renderings indicate identical or functionally similar elements.



FIG. 1 illustrates a perspective view of a catheter assembly having a balloon electrode tip in an inflated configuration according to an embodiment presented herein.



FIG. 2 illustrates a perspective view of the catheter assembly of FIG. 1 having the balloon electrode tip in a deflated configuration according to an embodiment presented herein.



FIG. 3A illustrates a perspective view of the balloon electrode tip of FIG. 1 with electrodes disposed on a distal end of the balloon according to an embodiment presented herein.



FIG. 3B illustrates a perspective view of the balloon electrode tip of FIG. 1 with electrodes disposed on a side of the balloon according to an embodiment presented herein.



FIG. 4 illustrates a perspective view of a catheter assembly having a balloon electrode tip in a deflated configuration according to an embodiment presented herein.



FIG. 5 illustrates a side view of a catheter assembly having a balloon electrode tip in an inflated configuration according to an embodiment presented herein.



FIG. 6 illustrates a longitudinal cross-sectional view of the catheter assembly of FIG. 5.



FIG. 7 illustrates an exploded side view of the catheter assembly of FIG. 5.



FIGS. 8A-8C illustrate perspective views of exemplary balloon shapes of balloon electrode tips according to embodiments presented herein.



FIG. 9A illustrates a side view of a catheter assembly having a balloon electrode tip in a deflated configuration according to an embodiment presented herein.



FIG. 9B illustrates a side view of the catheter assembly of FIG. 9A having the balloon electrode tip in an inflated configuration according to an embodiment presented herein.



FIG. 10 illustrates a side view of a catheter assembly having a balloon electrode tip in an inflated configuration according to an embodiment presented herein.





DETAILED DESCRIPTION OF THE INVENTION

Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. In case of conflict, the present application including the definitions will control. Also, unless otherwise required by context, singular terms shall include pluralities and plural terms shall include the singular. All publications, patents and other references mentioned herein are incorporated by reference in their entireties for all purposes.


The term “invention” or “present invention” as used herein is a non-limiting term and is not intended to refer to any single embodiment of the particular invention but encompasses all possible embodiments as described in the application.


According to some embodiments of the present invention, an electrosurgical balloon includes one or more electrodes integrated onto the exterior surface of an expandable balloon (i.e., a balloon that can be expanded by inflation with a gas or liquid). The balloon can formed of a non-conductive substrate material. The electrosurgical balloon can be incorporated into a catheter assembly. The balloon can be disposed at a distal end of an elongated medical device (e.g., a catheter) to provide the catheter with electrosurgical functionality. Catheter lead wire(s) that can be connected to a power source at a proximal end of the catheter are carried by the catheter to the catheter's distal end to connect with the electrode(s).


The one or more electrodes can be formed of any suitable material. For example, the electrode(s) can be a biocompatible conductive wire (such as stainless steel or titanium) adhered to the exterior surface of the balloon, or the electrode(s) can be formed of a conductive ink applied (e.g., by a printing or stamping process) to the surface of the balloon substrate material. The wire or conductive ink electrode(s) on the balloon's surface can include an exposed electrode portion (for tissue treatment at a surgical site) and a lead portion (formed of wire or conductive ink). The electrode lead portion can be soldered to a distal end portion of the catheter lead wire(s). The solder connections and the electrode lead portion can be insulated (e.g., using an insulative material (such as ink or paint that is nonconductive) deposited over a conductive ink electrode, or using an insulative sheath on a wire electrode). The conductive ink for forming an electrode can include ink or paint formed of conductive materials such as, for example, metallic particles (e.g., powdered or flaked silver), carbon, conductive polymers or similar materials. The conductive ink can also include a compliant material that allows dry conductive ink on the balloon to spread with balloon expansion, thereby maintaining the conductive pathway from the catheter lead wire to the electrode lead portion to the exposed electrode portion.


The proximal end of the balloon can be mounted to a rigid ring which is fed into the distal end of the catheter, and the rigid ring can be the site for soldering of the electrode lead portion with the catheter lead wire. The balloon can be made of compliant material (e.g., silicone, latex) or non-compliant material (e.g., PVC, PE, PET). The balloon material can be porous or non-porous with respect to the fluid used for inflation (e.g., saline). The balloon can have a double diameter (with a smaller diameter proximal end and a larger diameter distal end) for stability and to facilitate mounting to the catheter. The balloon can be any configuration or shape (e.g., tubular, spherical) and can be various sizes, allowing the balloon to be designed for a myriad of therapies. The size and shape of the balloon when inflated a given inflation amount can be tailored based on the anatomical site(s) where the balloon is intended to be deployed for an electrosurgical operation, as well as the size of the patient (e.g., sized for adult anatomies (i.e., a comparatively large balloon size) or sized for infant anatomies (i.e., a comparatively small balloon size)).


The electrosurgical balloon can be provided with a monopolar (single) electrode system or a bipolar (double) electrode system. The electrode(s) can be configured to provide an appropriate wattage for the treatment. For example, for bipolar RF treatments in some embodiments, the bipolar electrodes of the electrosurgical balloon can be supplied with RF energy in a range of from about 2 to about 60, from about 10 to about 50, from about 15 to about 45, or from about 10 to about 30 watts. In some embodiments, an electrosurgical procedure is conducted with the bipolar electrodes of the electrosurgical balloon using about 18 watts of RF energy. The level of electrical power used in conjunction with a bipolar system (as well as monopolar system) can be varied and optimized for a particular application, and, if sufficiently high, can generate heat sufficient to dissect, coagulate, or otherwise heat-treat the tissue to which it is applied. This can render the tissue suitable for a variety of surgical procedures, such as, for example, blunt dissection. Exemplary tissue treatment procedures that can employ the balloon electrodes described herein include, for example, dissection and coagulation as mentioned above, as well as blunt dissection with coagulation, spot coagulation, and coagulation of large tissue planes.


The inflation amount of a balloon is adjustable, thereby allowing individualized size adjustments at the surgical site of a particular patient. The inflation amount (measured by the internal pressure (e.g., psi) in the balloon) can be varied to improve the conformability of the balloon to tissue surfaces, even on irregular tissue surfaces. Greater conformability of the balloon to the tissue surface can increase the electrode area in contact with tissue, which may result in reduced treatment times and/or reduced power requirements. Non-compliant balloons can assure a distance between electrodes, and ensure the inflated balloon size and shape is substantially maintained to a predetermined configuration. The inflation amount can also be used to adjust the gap between bipolar electrodes if the balloon is compliant. For RF treatments, variation in the gap between bipolar electrodes can vary the RF application to the tissue. For example, the closer the bipolar electrodes are to each other the more focused the RF energy that is applied to the area between the electrodes, permitting deeper penetration of the RF energy into the tissue in that area. In some embodiments, one or more of the electrode(s) on the balloon surface are configured to deliver ultrasonic therapies. In some embodiments, the electrosurgical balloon is configured to provide both. RF applications and ultrasonic applications.


In some embodiments, a bipolar electrode pair is provided on the exterior surface of the balloon. The electrode pair includes a first electrode (e.g., active electrode) serving as a first pole of a bipolar electrode configuration and a second electrode (e.g., return electrode) serving as a second pole of the bipolar electrode configuration. The electrodes are separated from each other on the balloon's exterior surface, and are insulated from each other by the separation area formed by the non-conductive balloon substrate material. Weeping holes are provided in the balloon substrate material. After delivery to the treatment site in its deflated state, the balloon can be inflated with a fluid. A portion of the fluid can exit through the weeping holes. The weeping holes are specifically positioned in the balloon so as to ensure that fluid exiting the balloon is provided to the pair of electrodes so as to fluidly connect the electrodes together. In some embodiments, the fluid used to inflate the balloon is a conductive fluid (e.g., saline). The weeping holes in the balloon allow the conductive fluid to flow (“weep”) to the pair of electrodes. The wept conductive fluid produces an electric coupling to the treatment site by providing a conductive pathway for energy to flow between the pair of electrodes at the treatment site. Moreover, the weeping of fluid can mitigate any thermal expansion of the balloon arising from heat dissipating from the energized electrodes.


The weeping holes can be configured to open to release the conductive fluid only once the balloon has been expanded to a given inflation amount. For example, a complaint (e.g., silicone) balloon can be formed by dipping a mandrel in silicon and curing the silicon, as known to one of skill in the art. The mandrel can be configured to form a balloon having areas of differing thickness. For example, the mandrel can be provided with dimples (or alternatively, bumps), which form corresponding bumps (or alternatively, corresponding dimples) in the balloon that have a greater thickness than the remainder of the balloon. These bumps (or dimples) in the balloon serve as the sites for pin holes, which can be formed in the bumps (or dimples) of the balloon in the deflated configuration. The thickness of the bump (or dimple) to the size of the pin hole is such that the hole is effectively too small for release of the conductive fluid when the balloon is deflated, but opens to form the weeping hole once the balloon is inflated. Alternatively, the balloon can be provided with a uniform thickness (without dimples/bumps) so that the pin holes can be provided anywhere in the balloon. The balloon thickness to the size of the pin hole is such that the pin holes are too small for release of the conductive fluid when the balloon is deflated, but opens to form the weeping holes once the balloon is inflated. Alternatively or in addition to the weeping holes that are configured to open only upon balloon inflation, the balloon may be provided with weeping holes configured to be always open regardless of the state of inflation of the balloon.


In some embodiments, in addition to weeping holes, drug delivery holes can be provided in the balloon for delivery of drugs from a drug source to the treatment site. Thus, both electrosurgical and pharmaceutical-based therapies can be applied to the treatment site using the electrosurgical balloon.


In some embodiments, the electrosurgical balloon can include two balloons: an outer balloon and an inner balloon (see, e.g., catheter assembly 200 described below with references to FIGS. 5-7). The outer balloon can be provided with one or more electrodes on its exterior surface as described above. The inner balloon (disposed inside the chamber of the outer balloon) provides support to the outer balloon. Each of the inner and outer balloons can be made of a compliant or non-compliant material. Each of the inner and outer balloons are inflatable, and each can be inflated with a fluid from a fluid source. When the electrosurgical balloon is deployed (i.e., inflated at the treatment site), the outer balloon can be adjustably inflated with fluid, whereas the inner balloon can always filled with fluid (without adjustment).


In some embodiments, the outer balloon is made of a compliant material, and the inner balloon is made of a non-compliant material. In some embodiments, the outer balloon is made of a non-compliant material, and the inner balloon is made of a compliant material. In some embodiments, both the inner and outer balloons are made of a compliant material, and in other embodiments, both the inner and outer balloons are made of a non-compliant material. The fluid can be a gas (e.g., air) or a liquid (e.g., saline). In some embodiments, the outer balloon is configured to be inflated with a liquid, and the inner balloon is configured to be inflated with a gas. In some embodiments, the outer balloon is provided with a pair of electrodes having a bipolar electrode configuration. In such embodiments, the outer balloon can be selectively inflated with fluid from a fluid source and has weeping holes for dispensing the fluid to the pair of electrodes as earlier described. The inner balloon can be used for support and keeping the electrodes on the outer balloon in place during tissue treatment, while the outer balloon can be controlled to vary the inflation amount and pressure so as to control the amount of fluid that weeps, the surface area contact, and the distance between bipolar electrodes.


In some embodiments, the catheter can be slidably disposed within a lumen of an outer catheter. In some embodiments, the catheter can be fully retracted within the outer catheter so that the deflated balloon can reside in the lumen of the outer catheter until deployed at the treatment site. In some embodiments, the balloon is attached to both the distal end of the inner catheter and the distal end of the outer catheter. When the balloon is inflated, movement of the inner catheter relative to the outer catheter can force the balloon out of or into the lumen of the outer catheter, and the application of such force can change the shape and internal pressure of the balloon. This relative movement of the catheters can be used to control the balloon area in contact with the tissue. The movement can be used to control the amount of fluid that weeps and, for bipolar embodiments, the distance between bipolar electrodes.


In some embodiments, the catheter assembly constituted by the catheter and the electrosurgical balloon (serving as the balloon electrode tip) in its deflated configuration can extend through the lumen of a 2-French or larger catheter. In operation, the catheter assembly (including the inner catheter, the outer catheter if provided, and the electrosurgical balloon) can be delivered through a trocar to a percutaneous treatment site using a delivery system. As an example only and not by way of limitation, a delivery catheter is inserted through the trocar to a specific treatment site. A guidewire is inserted through the delivery catheter to the treatment site. The delivery catheter is removed, and the catheter assembly is advanced along the guidewire to the site. The electrosurgical balloon is extended from the outer catheter (if provided) at the site and inflated. The electrode(s) on the balloon's exterior surface are energized and targeted tissue is contacted with the energized balloon electrode tip. After the electrosurgical procedure is conducted, the guidewire and the catheter assembly are be removed either simultaneously or sequentially in any order.


The electrosurgical balloon according to embodiments presented herein allows increased surface area to be in contact with the targeted tissue beyond the standard 5 mm trocar diameter of typical laparoscopic instruments. Thus, a catheter assembly including the electrosurgical balloon allows delivery of a large electrode system through a small trocar. The electrosurgical balloon can allow electrosurgical procedures to be conducted using an electrode system that has a size and shape to achieve desired functionality and performance capabilities at the surgical site, with minimal or no size restrictions arising from the diameter of the catheter assembly, the trocar, and/or the delivery catheter.


Embodiments of the electrosurgical balloon described herein can be used for many procedures, including percutaneous treatment of aneurysms, treatment of mitral valve regurgitation by tightening the annulus around the mitral valve, treatments in the upper and lower gastrointestinal tract (GI) (including, e.g., bleeding varices, ulcers, caustic poisons, Crohn's disease), diverticulosis, varicose veins, sympathetic nerves (e.g., renal denervation by RF ablation), tumors, gene and stem cell therapies, and other surgical procedures in which treatment can include vessel sealing/coagulation, tissue shrinkage, and/or tissue ablation.


To further illustrate electrosurgical balloons and catheter assemblies disclosed herein, exemplary embodiments will now be described with reference to the Figures. It should be understood that any features of an embodiment disclosed herein can be combined with any features of any other embodiment disclosed herein, without departing from the scope of the present disclosure. Thus, any of the features of the electrosurgical balloons and catheter assemblies described above can be combined with any features of the exemplary embodiments described below with reference to the Figures.



FIGS. 1 and 2 illustrate an exemplary catheter assembly 100 according to an embodiment presented herein. Catheter assembly 100 includes an outer catheter 110, an inner catheter 130, and a balloon electrode tip 120. FIG. 1 illustrates balloon electrode tip 120 in an inflated configuration, and FIG. 2 illustrates tip 120 in a deflated configuration.


Outer catheter 110 has an elongated body 112 with a lumen 116. Lumen 116 can extend from a proximal end portion (not shown) to a distal end portion 114. Inner catheter 130 is disposed within lumen 116 of outer catheter 110. Inner catheter 130 has an elongated body 132 and a distal end portion 134. In some embodiments, balloon electrode tip 120 is attached to distal end portion 134 of inner catheter 130. In some embodiments, balloon electrode tip 120 is also attached to distal end portion 114 of outer catheter 110. FIG. 3A illustrates balloon electrode tip 120 (absent catheters 110 and 130). Balloon electrode tip 120 includes an inflatable balloon body 122 having an exterior surface 124 on which is disposed a pair of bipolar electrodes 156a and 156b. Balloon body 122 can be made of compliant or non-compliant material. Balloon body 122 can be inflated with a fluid (e.g., gas or liquid), and in some embodiments, balloon body is inflated with conductive fluid (e.g., saline) supplied from a fluid source. Inflation of balloon body 122 can be achieved by dispensing fluid into the interior chamber of balloon body 122 from one or more fluid outlet openings provided in either outer catheter 110 or inner catheter 130. In the embodiment shown in FIGS. 1 and 2, a plurality of fluid outlet openings 136 are provided in distal end portion 134 of inner catheter 130. Inner catheter 130 can have a lumen communicating with openings 136. The lumen forms a fluid channel for supplying fluid from a fluid source at a proximal end of inner catheter 130 to fluid outlet openings 136.


In embodiments where balloon body 122 is attached to outer catheter 110, fluid can be supplied into balloon body 122 via a fluid supply lumen in outer catheter 110. Fluid supply from outer catheter 110 (not shown) can be an alternative to or in addition to dispensing fluid from inner catheter 130 via openings 136. For example, outer catheter 110 can include a lumen that communicates with the interior chamber of balloon body 122 for filling balloon body 122 with fluid supplied from the lumen.


Balloon body 122 is provided with a plurality of weeping holes 126 which expel a portion of the fluid inflating balloon body 122. In some embodiments as described above, weeping holes 126 can be configured as valves that remain closed when balloon body 122 is deflated but which are opened when balloon body 122 is inflated to a given minimum inflation amount and/or internal pressure.


Electrodes 156a and 156b can be placed anywhere on exterior surface 124 of balloon body 122. In the embodiments shown in FIGS. 1, 2 and 3A, electrodes 156a and 156b are disposed on the distal end of balloon body 122 (e.g., at hemispherical portion 164). Such electrode placement may be desirable for therapies requiring clearing of clogged vessels, whereby the electrodes at the distal end can be used to ablate the clogging tissue. For therapies requiring sealing of vessels or removal of tissue at sidewalls of a body lumen, it may be desirable to position electrodes 156a and 156b at a side of balloon body 122 (e.g., at cylindrical portion 162a), such as illustrated in an embodiment of a balloon electrode tip 120′ shown in FIG. 3B. As shown in the embodiments of FIGS. 3A and 3B, weeping holes 126 are located in balloon body 122 in a region extending between the electrodes 156a and 156b. When conductive fluid is used to inflate balloon body 122 and weeps from holes 126, the wept conductive fluid exists in the region extending between the electrodes 156a and 156b and provides an electrical pathway adjoining electrodes 156a and 156b. In this manner, the placement of weeping holes 126 is determined in relation to the placement of electrodes 156a and 156b to ensure that fluid exiting the weeping holes 126 is provided to the electrodes to fluidly connect them together.


In the embodiment shown in FIGS. 1, 2, 3A and 3B, bipolar electrodes 156a and 156b are formed of conductive ink and include respective exposed, conductive electrode portions (at 156a and 156b) and respective lead portions 158a and 158b, whose exterior surfaces have been covered by an insulative material 155. Electrode lead portions 158a and 158b (and insulative material 155) extend proximally from the exposed electrode portions to a proximal portion 166 of balloon body 122 (see FIG. 3A). At proximal portion 166 of balloon body 122, electrode lead portions 158a and 158b meet catheter lead wires 118a and 118b (shown in phantom in FIGS. 1 and 2) at distal end portion 114 of outer catheter 110. Catheter lead wires 118a and 118b are connected to a power source (not shown) at the proximal end portion of outer catheter 110.


In some embodiments, a rigid ring 140 can be mounted on the exterior of a cylindrical portion 166a (see FIG. 3A) of proximal portion 166 over electrode lead portions 158a and 158b. As shown in FIGS. 1 and 2, the catheter lead wires 118a and 118b can extend onto the interior surface of ring 140 facing the cylindrical portion 166a to meet electrode lead portions 158a and 158b at a solder site 159, and ring 140 can serve as a substrate for soldering of electrode lead portions 158a and 158b to the catheter lead wires 118a and 118b at solder site 159. In the embodiment of FIGS. 1 and 2, ring 140 is secured within lumen 116 of outer catheter 110 (e.g., by an interference fit, adhesive, a bayonet locking mechanism, and/or other known attachment methods), thereby attaching proximal portion 166 of balloon body 122 to distal end portion 114 of outer catheter 110. Other methods as known in the art can also be employed for attaching proximal portion 166 of the balloon body to the outer catheter 110.


A distal portion of balloon body 120 can be attached to distal end portion 134 of inner catheter 130. As shown in FIG. 3A, balloon body 122 can include a distal portion 162 having a hemispherical portion 164 extending proximally to a cylindrical portion 162a. Hemispherical portion 164 includes an attachment portion 128 at a distal end 129b of balloon body 122. Attachment portion 128 attaches to distal end portion 134 of inner catheter 130. In some embodiments, attachment portion 128 is a rigid ring which can be secured to the outside of inner catheter (as shown in FIGS. 1 and 2) or secured within a lumen of inner catheter 130. The attachment between attachment portion 128 and inner catheter 130 can be achieved by an interference fit, adhesive, a bayonet locking mechanism, and/or other known attachment methods. Other methods as known in the art can also be employed for attaching of balloon body 122 to inner catheter 130 at distal end 129b of balloon body 122.


At a proximal end 129a of balloon body 122 (extending proximally from cylindrical portion 166a) is a cylindrical portion which forms a throat 123 of balloon body 122. Throat 123 has a proximal opening 123a for receiving inner catheter 130 into the interior chamber of balloon body 122. Throat 123 can have a diameter corresponding to either the outer diameter of inner catheter 130. Inner catheter 130 and throat 123 can have a fluid-tight sealing engagement, thereby permitting fluid dispensed from outlet openings 136 to fill the interior chamber of balloon body 122 and inflate balloon body 122.


When balloon body 122 is inflated, cylindrical portion 162a of distal portion 162 can abut against the distal end of outer catheter 110 as shown in FIG. 1. In some embodiments, distal end portion 114 of outer catheter 110 can be made of softer durometer material than the proximal end portion of outer catheter 110, to help prevent distal end portion 114 from compromising the elasticity of balloon body 122 (if made of compliant material), and/or to prevent piercing balloon body 122 once inflated.


In some embodiments, as shown in FIGS. 3A and 3B, balloon body 122 has a double diameter, in which distal portion 162 of balloon body 122 has one diameter and proximal portion 166 has another diameter. In the embodiments of FIGS. 3A and 3B, cylindrical portion 166a extending proximally from cylindrical portion 162a has a diameter that is less than that of cylindrical portion 162a in an inflated configuration. In some embodiments, balloon body 122 is attached to outer catheter 110 via ring 140, such as described above with reference to FIGS. 1 and 2. In such embodiments, the diameter of proximal cylindrical portion 166a can correspond with the diameter of ring 140 and likewise the inner diameter of lumen 116 which receives ring 140. Thus, cylindrical portion 166a can serve as a site where balloon body 122 is attached to outer catheter 110. Cylindrical portion 166a can also serve as a supporting base for distal cylindrical portion 162a to provide stability to distal portion 162 of balloon body 122. Enhancing the stability of distal portion 162 can help ensure that the exposed electrode portions of electrodes 156a and 156b on distal portion 162 can be steadily placed in contact with target tissue. In the embodiments of FIGS. 3A and 3B, distal portion 162 has a larger diameter than proximal portion 166 in an inflated configuration. In other embodiments, a double diameter balloon body can be provided in which distal portion 162 has a smaller diameter than proximal portion 166 in an inflated configuration.



FIG. 4 illustrates a catheter assembly 100′ according to an embodiment presented herein. Catheter assembly 100′ is a variation of catheter assembly 100 and differs in that balloon body 122 is not attached to outer catheter 110. In FIG. 4, elements with similar or identical function and configuration as those previously described for catheter assembly 100 are denoted with identical reference numbers, and therefore detailed explanation of such elements may be omitted or abbreviated. In the embodiment of FIG. 4 (showing balloon body 122 in its deflated configuration), balloon body 122 is attached to inner catheter 130 at attachment portion 128 (at distal end 129b, see FIG. 3A) and at throat 123 (at proximal end 129a, see FIG. 3A). A rigid ring 140′ is provided around the exterior of throat 123 and serves as a soldering substrate for electrically connecting electrode lead portions 158a and 158b with catheter lead wires 118a and 118b at solder site 159 (catheter lead wires not shown in the view of FIG. 4; see, e.g., catheter lead wires 118a and 118b shown the embodiment of FIGS. 1 and 2). In the embodiment of FIG. 4, ring 140′ crimps throat 123 onto the outside of inner catheter 130, and provides a fluid-tight seal between throat 123 of balloon body 122 and distal end portion 134 of inner catheter 130. Other methods as known in the art can also be employed for attaching of balloon body 122 to inner catheter 130 at throat 123.


In any of the embodiments described herein, inner catheter 130 can be slidably disposed within lumen 116 of outer catheter 110. In the embodiment of FIGS. 1 and 2, at least a portion of distal end portion 134 of inner catheter can be retracted inside lumen 116. In some embodiments, distal end portion 134 of inner catheter can retract a majority of deflated balloon body 122 inside lumen 116, which can provide protection to balloon electrode tip (e.g., tip 120 or 120′ or other electrode tip embodiments described herein) until deployment at the surgical site. In comparison with catheter assembly 100, because balloon body 122 is not attached to outer catheter 110 in the embodiment of FIG. 4, distal end 134 of inner catheter 130 can retract the entirety of balloon body 122 inside lumen 116 of outer catheter 110.


The inflation amount and internal pressure of balloon body 122 can be varied to control the fluid flow rate of fluid from weeping holes 126 and to assist in achieving desired electrode contact on tissue surfaces. Moreover, the inflation amount and internal pressure of balloon body 122 can be varied to control the distance between bipolar electrodes 156a and 156b if the balloon body is made of compliant material. The inflation amount and internal pressure can be controlled by adjusting the amount of fluid dispensed into the internal chamber of balloon body 122 (via outlet openings 136) (i.e., the inflation amount) and/or by manipulating the position of distal end portion 134 of inner catheter 130 relative to distal end portion 114 of outer catheter 110. Adjustment of the inflation amount can be independent of or in conjunction with the manipulation of the relative position of the distal end portions of the inner and outer catheters.


As an illustration, in the embodiments of FIGS. 1, 2 and 4, when balloon body 122 is inflated, proximal movement of inner catheter distal end portion 134 relative to outer catheter distal end portion 114 can pinch balloon distal portion 162 against outer catheter distal end portion 114. This pinching action can cause a portion of balloon body 122 to collapse into outer catheter lumen 116, forcing fluid in the interior chamber of balloon body 122 into the remaining portion of balloon body 122 outside of lumen 116. The additional fluid increases the internal pressure and can increase the flow rate of fluid from weeping holes 126. For electrode positioning at the distal end of the balloon body such as in the embodiment of FIG. 3A, proximal movement of inner catheter 130 also pulls distal end 129b of balloon body 122 proximally (via their attachment at distal attachment portion 128), which causes electrodes 156a and 156b to be pushed distally inward closer together. For embodiments where proximal portion 166 of balloon body 122 is attached to outer catheter distal end portion 114 (see FIGS. 1 and 2), distal movement of inner catheter distal end portion 134 can elongate balloon body 122, which can cause electrodes 156a and 156b to be pushed away from each other, increasing their separation distance. The extent of balloon elongation can change the shape of a complaint balloon body so that electrodes 156a and 156b initially disposed at the distal end of the balloon body are moved to a side of the elongated balloon body. Additional fluid can be dispensed from inner catheter outlet openings 136 to cause further expansion of the remaining portion of balloon body 122 to change the fluid flow rate and/or the distance between electrodes 156a and 156b. As should be apparent, manipulation of balloon shape (via inflation amount and/or relative movement of the inner and outer catheters) may achieve a different result for different electrode positioning. For example, for electrodes on a side of the balloon body such as in the embodiment of FIG. 3B, the remaining portion of balloon body 122 (not collapsed in outer catheter 110) can expand under the increased pressure if balloon body is compliant. This can cause electrodes 156a and 156b to move apart despite distal end 129b of balloon body 122 being pulled proximally by proximal movement of inner catheter 130.


Weeping holes 126 can be configured to close when the balloon body is deflated and open when the balloon body 122 is inflated to a given minimum inflation amount and/or internal pressure. Increasing the inflation amount and/or internal pressure (beyond the minimum which opens holes 126) can increase the flow rate of fluid from holes 126, which may be desired to control the temperature at the treatment site. The flow rate of the electrically conductive fluid can affect the thermal characteristics of the tissue. For RF applications for example, when the fluid is electrically conductive fluid, the fluid can act as a heat sink, absorbing and carrying away excess or undesirable thermal energy resulting from electrically energizing electrodes 156a and 156b. The electrically conductive fluid can also provide electrical dispersion by distributing the applied current over a larger surface area, thereby limiting the potential for undesirable thermal concentration. An uncontrolled or abundant flow rate can provide too much electrical dispersion and cooling at the electrode/tissue interface. On the other hand, a flow rate that is too low could lead to excessive heat and arcing.


Moreover, the electrically conductive fluid can be used to help maintain temperatures within ranges conducive to coagulation of tissue (e.g., temperatures hot enough to denature the collagen and most soft tissue and bone, however not so hot that tissue is damaged to such an extent that it cannot be easily absorbed back into the body during a healing process) as opposed to charred, desiccated tissue. Collagen shrinkage, which causes coagulation, is a function of time and temperature. At 100° C., coagulation occurs substantially instantaneously, and at higher temperatures there will also be coagulation. Coagulation can begin at temperatures lower than 100° C., but the coagulation may occur more gradually. Without fluid (e.g., saline) present at the tissue being treated, temperatures can quickly rise above 100° C., and at such higher temperatures there is a greater likelihood of tissue sticking and charring. As one of skill in the art would appreciate, the time and temperature applied can be varied to suit a particular use. An RF power system can be controlled by suitable software to obtain desired power delivery characteristics. For example, in some embodiments, a control device or custom generator can be configured to allow the user to select a “pulse” mode of the RF power whereby the RF power to the balloon electrode tip is repeatedly turned on and off. Pulsed RF power may help effectively treat thick tissues as would be would be recognized by one of skill in the art. Moreover, in some embodiments, fluid flow rates from weeping holes 126 can be controlled based on the applied RF power to maintain temperatures at the treatment site within a desired range.


In embodiments described herein, saline has been provided as the exemplary electrically conductive fluid for filling balloon body 122 and expelling through weeping holes 126; however other electrically conductive fluids may be used alternatively or additionally, consistent with the embodiments presented herein. The fluid for filling balloon body 122 and expelling through weeping holes 126 may also comprise an electrically non-conductive fluid (e.g., deionized water and lactated ringers). The use of a non-conductive fluid still provides certain advantages over the use of a dry electrode including, for example, reduced occurrence of tissue sticking to the electrodes of the tip assemblies disclosed herein, and cooling of the electrodes and/or tissue.


In some embodiments, balloon electrode tip 120 (or 120′) is provided with an inner balloon body (disposed inside the interior chamber of balloon body 122). An inner balloon body can provide balloon electrode tip 120 with a double-wall construction that is more resistant to displacement. The inner balloon body can serve as a support for electrode tip 120 to enhance the stability of balloon body 122 and help ensure that the exposed electrode portions of electrodes 156a and 156b on distal portion 162 can be steadily placed in contact with target tissue. The outer balloon body 122 can be adjustably inflated with fluid to vary its shape or internal pressure to control fluid flow rate from weeping holes 126, vary the distance between electrodes and/or achieve desired electrode contact on tissue surfaces. In some embodiments, the inner balloon body can always be filled with fluid once deployed (without adjustment).


An exemplary embodiment of a catheter assembly 200 having a double-wall construction formed by inner and outer balloons will now be described with reference to FIGS. 5-7. In these figures, elements with similar or identical function and configuration as those previously described for catheter assembly 100 are denoted with identical reference numbers, and detailed explanation of such elements may be omitted or abbreviated in the description that follows.


Catheter assembly 200 includes a double-walled balloon electrode tip 220 having an outer balloon body 222 and an inner balloon body 272. Outer balloon body 222 has an exterior surface 224 (on which one or more electrodes are disposed, not shown) and an interior chamber 222a within which is disposed inner balloon body 272. Inner balloon body 272 has an interior chamber 272a. The distal end of inner balloon body 272 is attached to distal end portion 134 of inner catheter 130 at an attachment portion 278a. The proximal end of inner balloon body 272 has a throat 273 with a proximal opening 273a for receiving distal end portion 134 of inner catheter 130 into interior chamber 272a. Throat 273 can have a diameter corresponding to the outer diameter of inner catheter 130. Inner catheter 130 and throat 273 can have a fluid-tight sealing engagement at attachment portion 278b (see FIG. 6), thereby permitting fluid dispensed from outlets in inner catheter 130 (such as outlet openings 136, see FIGS. 1 and 2) to fill interior chamber 272a of inner balloon body 272 and inflate inner balloon body 272. The distal end of outer balloon body 222 is also attached to distal end portion 134 of inner catheter 130 at an attachment portion 228 (similar to earlier-described attachment portion 128 of balloon body 122). Outer balloon attachment portion 228 is located distally from inner balloon attachment portion 278a. The proximal end of outer balloon body 222 is attached to distal end portion of 114 of outer catheter 110 (similar to earlier-described balloon body 122 of catheter assembly 100). In some embodiments, inner balloon body 272 and outer balloon body 222 are independently inflatable. Fluid can be dispensed from outlets in inner catheter 130 (such as outlet openings 136, see FIGS. 1 and 2) into chamber 222a of outer balloon body 222. Alternatively, fluid can be dispensed into chamber 222a of outer balloon body 222 from outlets provided in outer catheter 110. Alternatively, fluid can be dispensed into chamber 222a of outer balloon body 222 from fluid inflating chamber 272a of inner balloon body (e.g., via fluid outlet holes provided in inner balloon body 272).


A ring (such as ring 140) can be used to attach outer balloon body 222 to outer catheter 110, and a ring (such as ring 140′) can be used to attach throat 273 of inner balloon catheter 272 to inner catheter 130. The attachment configurations illustrated in the embodiment of FIGS. 5-7 are exemplary only, and it should be understood that other methods as known in the art can also be employed for attaching of the inner and outer balloon bodies 272 and 222 to the inner and outer catheters 130 and 110. In some embodiments, outer balloon body 222 can have its proximal end attached to inner catheter 130 instead of being attached to outer catheter 110 (similar to earlier-described balloon body 122 of catheter assembly 100′).


Electrode(s), weeping holes and fluid outlets in the balloon bodies and catheters have been omitted from illustration in the views of FIGS. 5-7; however, it should be understood that catheter assembly 200 can be provided with fluid outlet opening(s) (such as outlet openings 136) in inner catheter 130 for dispensing fluid to inflate inner balloon body 272, and fluid outlet opening(s) in inner or outer catheters 130 and 110 for inflating outer balloon body 222, as earlier described. It should be understood that catheter assembly 200 can also be provided with one or more electrodes, including in some embodiments a bipolar electrode pair (such as electrodes 156a and 156b), and weeping holes (such as holes 126) configured to provide fluid to the bipolar electrode pair, as earlier described. It should also be understood that any of the features of a balloon electrode tip described herein (including but not limited to the features described with reference to a balloon electrode tip having a single balloon body, such as the features described with reference to catheter assemblies 100 and 100′ of FIGS. 1, 2, 3A, 3B, and 4), are applicable to a double-wall balloon electrode tip having two balloon bodies (e.g., balloon electrode tip 220 of catheter assembly 200). Therefore, further detailed description of such features with respect to embodiments of a double-wall balloon electrode tip is omitted for brevity.


The foregoing description of the specific embodiments of the devices and methods described with reference to the Figures will so fully reveal the general nature of the invention that others can, by applying knowledge within the skill of the art, readily modify and/or adapt for various applications such specific embodiments, without undue experimentation, without departing from the general concept of the present invention. For example, as earlier noted, the balloon electrode can have a balloon body of any configuration or shape (e.g., tubular, spherical, etc.) and can be various sizes, allowing the balloon to be designed for a myriad of therapies. FIGS. 8A-8C illustrate perspective views of exemplary balloon shapes of balloon electrode tips 120a, 120b, and 120c according to embodiments presented herein. In these illustrations, attachment of balloon electrode tips 120a, 120b, and 120c to inner catheter 130 is also shown. Balloon electrode tip 120a has a balloon body with an elliptical central portion tapering to opposite cylindrical end portions that attach to inner catheter 130 and have the same contour as inner catheter 130. Balloon electrode tip 120b is similar to tip 120a but has a blunted distal end portion where the balloon body has been folded inward to attach to inner catheter 130 (comparable to the attachment configurations of balloon bodies 122 and 222 to inner catheter 130 in the embodiments of FIGS. 1, 2, 4 and 5-7). Balloon electrode tip 120c has a cylindrical balloon body having blunted proximal and distal end portions where the balloon body attaches at proximal and distal ends thereof to the inner catheter 130.


Also, in any of the embodiments disclosed herein, a biocompatible conductive wire can used for the one or more balloon electrodes in place of a conductive ink electrode, and vice versa. Thus, conductive ink electrodes 156a and 156b can be replaced with wire electrodes. In some embodiments, the exposed electrode portions of electrodes 156a and 156b can be formed of conductive ink, and their lead portions 158a and 158b can be formed of wire leads. In embodiments using wire electrodes on the exterior surface of the balloon body, the wire electrode should be configured to extend with balloon expansion. An exemplary configuration of a wire electrode 156′ having a wire lead portion 158′ is illustrated in FIGS. 9A and 9B. As shown in FIG. 9A, a balloon electrode tip 120d has wire electrode 156′ provided on exterior surface 124 of a deflated balloon body 122′. Wire lead portion 158′ has a zigzag configuration along the length of deflated balloon body 122′. As shown in FIG. 9B, inflation of balloon body 122′ causes wire lead portion 158′ to extend longitudinally and straighten. Thus, the prior zigzag configuration of wire lead portion 158′ is straightened with balloon inflation.


Also, in any of the embodiments disclosed herein, the one or more balloon electrodes can be placed anywhere on the exterior surface of the balloon body. As described above with reference to FIGS. 3A and 3b, in some embodiments, a pair of bipolar electrodes (e.g., electrodes 156a and 156b) can be being disposed on the exterior surface the balloon body (e.g., balloon body 122) at one of the side and the distal end of the balloon body. Other electrode placements can also be employed. For example, one electrode of a bipolar electrode pair can be placed at the distal end of the balloon body and the other electrode can be placed at the side. Another exemplary configuration of an electrode placement is illustrated in FIG. 10. As shown in FIG. 10, a balloon electrode tip 120e includes a pair of bipolar electrodes 156a′ and 156b′ provided on exterior surface 124 of a balloon body 122″. Balloon body 122″ has a cylindrical central portion extending to a conically-shaped distal end portion. Bipolar electrodes 156a′ and 156b′ extend helically around these cylindrical and conical portions of balloon body 122″. With such a configuration, energization of helical electrodes 156a′ and 1566 provides a greater tissue treatment area proximally (at the cylindrical portion) than distally (at the conical portion). The conical portion can provide focused energy over a smaller tissue treatment area, which may be particular useful for blunt dissection of tissue. The cylindrical portion, which can target a greater tissue treatment area, may be particularly useful for tissue sealing.


In any of these embodiments of the exemplary balloon electrode tips 120a-e illustrated in FIGS. 8A-8C, 9A-9B, and 10, a catheter assembly can constitute the balloon electrode tip and the inner catheter 130. In some embodiments, the catheter assembly can further include outer catheter 110 (see, e.g., FIGS. 1, 2, and 5-7). As earlier described, outer catheter 110 can be configured to house inner catheter 130 and also house all or part of the collapsed balloon electrode tip. At the target surgical site, inner catheter distal end portion 134 can be extended from outer catheter distal end portion 114, and the balloon electrode tip then deployed. As should be apparent, in any of these embodiments, balloon electrode tips 120a-e can be modified to also attach to outer catheter 110 (comparable to the attachment configurations of balloon body 122 and balloon body 222 in the embodiments of FIGS. 1, 2 and 5-7). As also should be apparent, in any of these embodiments, balloon electrode tips 120a-e can be modified to have a double balloon configuration, i.e., be provided with an inner balloon body (such as inner balloon body 272) disposed within the chambers of the balloon bodies illustrated in FIGS. 8A-8C, 9A-9B, and 10.


Also, for example, in some embodiments the bipolar balloon electrode tips described herein can be used as a selectably monopolar tip, switchable between a bipolar mode and a monopolar mode. In the monopolar mode, at least one of the electrodes 156a and 156b is connected to a power generator so as to deliver energy as a monopolar (active) electrode, and there is no return electrode on the device (rather, a ground pad on the patient may be used as known in the art). A monopolar electrode system can be particularly suitable for ablating tissue. In some embodiments, the monopolar electrode may be supplied with RF energy (including pulsed RF energy), ultrasonic energy, or any other suitable energy for ablating tissue.


Therefore, it should be apparent that adaptations and modifications are intended to be within the meaning and range of equivalents of the disclosed embodiments, based on the teaching and guidance presented herein. It is to be understood that the phraseology or terminology herein is for the purpose of description and not of limitation, such that the terminology or phraseology of the present specification is to be interpreted by the skilled artisan in light of the teachings and guidance. The breadth and scope of the present invention should not be limited by any of the above-described exemplary embodiments, but should be defined only in accordance with the following claims and their equivalents.

Claims
  • 1. An electrosurgical balloon, comprising: an inflatable balloon body having a proximal end and a distal end and defining a circumference, wherein the balloon body is formed of a nonconductive substrate material;a pair of bipolar electrodes disposed on an opposite sides of an exterior surface of the inflatable balloon body, the pair of electrodes including a first electrode and a second electrode in a bipolar electrode configuration, each the first electrode and the second electrode extending partially around the circumference of the inflatable balloon body; andat least one fluid outlet hole in the balloon body configured to provide a conductive fluid from a fluid source to the pair of bipolar electrodes.
  • 2. The electrosurgical balloon of claim 1, wherein the balloon body is configured to be adjustably inflated with the conductive fluid from the fluid source.
  • 3. The electrosurgical balloon of claim 2, wherein adjustment of an amount of inflation of the balloon body is configured to adjust a separation distance between the first and second electrodes.
US Referenced Citations (554)
Number Name Date Kind
2888928 Seiger Jun 1959 A
3682130 Jeffers Aug 1972 A
3750650 Ruttgers Aug 1973 A
4060088 Morrison, Jr. et al. Nov 1977 A
4195637 Gruntzig et al. Apr 1980 A
4207897 Lloyd et al. Jun 1980 A
4244371 Farin Jan 1981 A
4248224 Jones Feb 1981 A
4275734 Mitchiner Jun 1981 A
4276874 Wolvek et al. Jul 1981 A
4278090 van Gerven Jul 1981 A
4321931 Hon Mar 1982 A
4342218 Fox Aug 1982 A
4355642 Alferness Oct 1982 A
4377168 Rzasa et al. Mar 1983 A
4381007 Doss Apr 1983 A
4519389 Gudkin et al. May 1985 A
4598698 Siegmund Jul 1986 A
4601290 Effron et al. Jul 1986 A
4664110 Schanzlin May 1987 A
4671274 Scrochenko Jun 1987 A
4736749 Lundback Apr 1988 A
4779611 Grooters et al. Oct 1988 A
4802475 Weshahy Feb 1989 A
4919129 Weber et al. Apr 1990 A
4931047 Broadwin et al. Jun 1990 A
4932952 Wojciechowicz, Jr. Jun 1990 A
4943290 Rexroth et al. Jul 1990 A
4950232 Ruzicka et al. Aug 1990 A
4985030 Melzer et al. Jan 1991 A
4998933 Eggers et al. Mar 1991 A
5047028 Qian Sep 1991 A
5190541 Abele et al. Mar 1993 A
5195959 Smith Mar 1993 A
5234428 Kaufman Aug 1993 A
5254117 Rigby et al. Oct 1993 A
5281215 Midler Jan 1994 A
5309896 Moll et al. May 1994 A
5316000 Chapelon et al. May 1994 A
5317878 Bradshaw et al. Jun 1994 A
5318525 West et al. Jun 1994 A
5322520 Milder Jun 1994 A
5323781 Ideker et al. Jun 1994 A
5324255 Passafaro et al. Jun 1994 A
5324284 Imran Jun 1994 A
5324286 Fowle Jun 1994 A
5330521 Cohen Jul 1994 A
5334181 Rubinsky et al. Aug 1994 A
5334193 Nardella Aug 1994 A
5336220 Ryan et al. Aug 1994 A
5348554 Imran et al. Sep 1994 A
5353783 Nakao et al. Oct 1994 A
5354258 Dory Oct 1994 A
5361752 Moll et al. Nov 1994 A
5383874 Jackson et al. Jan 1995 A
5385148 Lesh et al. Jan 1995 A
5395312 Desai Mar 1995 A
5396887 Imran Mar 1995 A
5397304 Truckai Mar 1995 A
5400770 Nakao et al. Mar 1995 A
5400783 Pomeranz et al. Mar 1995 A
5401272 Perkins Mar 1995 A
5403309 Coleman et al. Apr 1995 A
5403311 Abele et al. Apr 1995 A
5405376 Mulier et al. Apr 1995 A
5409483 Campbell et al. Apr 1995 A
5417709 Slater May 1995 A
5423807 Milder Jun 1995 A
5423811 Imran et al. Jun 1995 A
5427119 Swartz et al. Jun 1995 A
5431168 Webster, Jr. Jul 1995 A
5431649 Mulier et al. Jul 1995 A
5433708 Nichols et al. Jul 1995 A
5435308 Gallup et al. Jul 1995 A
5437651 Todd et al. Aug 1995 A
5441503 Considine et al. Aug 1995 A
5443463 Stern et al. Aug 1995 A
5443470 Stern et al. Aug 1995 A
5445638 Rydell et al. Aug 1995 A
5450843 Moll et al. Sep 1995 A
5452582 Longsworth Sep 1995 A
5452733 Sterman et al. Sep 1995 A
5460629 Shlain et al. Oct 1995 A
5462545 Wang et al. Oct 1995 A
5465717 Imran et al. Nov 1995 A
5469853 Law et al. Nov 1995 A
5472876 Fahy Dec 1995 A
5478309 Sweezer et al. Dec 1995 A
5478330 Imran et al. Dec 1995 A
5486193 Bourne et al. Jan 1996 A
5487385 Avitall Jan 1996 A
5487757 Truckai et al. Jan 1996 A
5490819 Nicholas et al. Feb 1996 A
5496271 Burton et al. Mar 1996 A
5496312 Klicek Mar 1996 A
5497774 Swartz et al. Mar 1996 A
5498248 Milder Mar 1996 A
5500012 Brucker et al. Mar 1996 A
5505700 Leone Apr 1996 A
5505730 Edwards Apr 1996 A
5516505 McDow May 1996 A
5520682 Baust et al. May 1996 A
5522870 Ben-Zion Jun 1996 A
5536267 Edwards et al. Jul 1996 A
5540562 Giter Jul 1996 A
5540679 Fram et al. Jul 1996 A
5542916 Hirsch et al. Aug 1996 A
5542945 Fritzsch Aug 1996 A
5545195 Lennox et al. Aug 1996 A
5545200 West et al. Aug 1996 A
5549661 Kordis et al. Aug 1996 A
5555883 Avitall Sep 1996 A
5556397 Long et al. Sep 1996 A
5558671 Yates Sep 1996 A
5560362 Silwa, Jr. et al. Oct 1996 A
5562702 Huitema et al. Oct 1996 A
5562720 Stern et al. Oct 1996 A
5569241 Edwards Oct 1996 A
5569243 Kortenbach et al. Oct 1996 A
5571088 Lennox et al. Nov 1996 A
5571215 Sterman et al. Nov 1996 A
5573424 Poppe Nov 1996 A
5573532 Chang et al. Nov 1996 A
5575766 Swartz et al. Nov 1996 A
5575788 Baker et al. Nov 1996 A
5575810 Swanson et al. Nov 1996 A
5578007 Imran Nov 1996 A
5582609 Swanson et al. Dec 1996 A
5588432 Crowley Dec 1996 A
5590657 Cain et al. Jan 1997 A
5595183 Swanson et al. Jan 1997 A
5599346 Edwards et al. Feb 1997 A
5605539 Buelna et al. Feb 1997 A
5607422 Smeets et al. Mar 1997 A
5607462 Imran Mar 1997 A
5617854 Munsif Apr 1997 A
5630837 Crowley May 1997 A
5637090 McGee et al. Jun 1997 A
5643197 Brucker et al. Jul 1997 A
5647869 Goble et al. Jul 1997 A
5656029 Imran et al. Aug 1997 A
5658278 Imran et al. Aug 1997 A
5671747 Connor Sep 1997 A
5673695 McGee et al. Oct 1997 A
5676662 Fleischhacker et al. Oct 1997 A
5676692 Sanghvi et al. Oct 1997 A
5676693 Lafontaine Oct 1997 A
5678550 Bassen et al. Oct 1997 A
5680860 Imran Oct 1997 A
5681278 Igo et al. Oct 1997 A
5681294 Osborne et al. Oct 1997 A
5681308 Edwards et al. Oct 1997 A
5687723 Avitall Nov 1997 A
5687737 Branham et al. Nov 1997 A
5688267 Panescu et al. Nov 1997 A
5690611 Swartz et al. Nov 1997 A
5697536 Eggers et al. Dec 1997 A
5697882 Eggers et al. Dec 1997 A
5697925 Taylor Dec 1997 A
5697927 Imran et al. Dec 1997 A
5697928 Walcott et al. Dec 1997 A
5713942 Stern Feb 1998 A
5716389 Walinsky et al. Feb 1998 A
5718241 Ben-Haim et al. Feb 1998 A
5718701 Shai et al. Feb 1998 A
5720775 Larnard Feb 1998 A
5722402 Swanson et al. Mar 1998 A
5730074 Peter Mar 1998 A
5730127 Avitall Mar 1998 A
5730704 Avitall Mar 1998 A
5733280 Avitall Mar 1998 A
5735280 Sherman et al. Apr 1998 A
5735290 Sterman et al. Apr 1998 A
5743903 Stern et al. Apr 1998 A
5746224 Edwards May 1998 A
5755760 Maguire et al. May 1998 A
5766167 Eggers et al. Jun 1998 A
5769846 Edwards et al. Jun 1998 A
5782828 Chen et al. Jul 1998 A
5785706 Bednarek Jul 1998 A
5788636 Curley Aug 1998 A
5792140 Tu et al. Aug 1998 A
5797905 Fleischman et al. Aug 1998 A
5797960 Stevens et al. Aug 1998 A
5800428 Nelson et al. Sep 1998 A
5800482 Pomeranz et al. Sep 1998 A
5810764 Eggers et al. Sep 1998 A
5810802 Panescu et al. Sep 1998 A
5827216 Igo et al. Oct 1998 A
5836947 Fleischman et al. Nov 1998 A
5840030 Ferek-Petric et al. Nov 1998 A
5843021 Edwards et al. Dec 1998 A
5843152 Tu et al. Dec 1998 A
5844349 Oakley et al. Dec 1998 A
5846187 Wells et al. Dec 1998 A
5846191 Wells et al. Dec 1998 A
5849028 Chen Dec 1998 A
5861021 Thome et al. Jan 1999 A
5871523 Fleischman et al. Feb 1999 A
5871525 Edwards et al. Feb 1999 A
5873845 Cline et al. Feb 1999 A
5873855 Eggers et al. Feb 1999 A
5876399 Chia et al. Mar 1999 A
5879295 Li et al. Mar 1999 A
5879296 Ockuly et al. Mar 1999 A
5879348 Owens et al. Mar 1999 A
5881732 Sung et al. Mar 1999 A
5882346 Pomeranz et al. Mar 1999 A
5885278 Fleischman Mar 1999 A
5891142 Eggers et al. Apr 1999 A
5893848 Negus et al. Apr 1999 A
5895355 Schaer Apr 1999 A
5895417 Pomeranz et al. Apr 1999 A
5897553 Mulier et al. Apr 1999 A
5897554 Chia et al. Apr 1999 A
5899898 Arless et al. May 1999 A
5899899 Arless et al. May 1999 A
5902289 Swartz et al. May 1999 A
5904711 Flom et al. May 1999 A
5906580 Kline-Schoder et al. May 1999 A
5906587 Zimmon May 1999 A
5906606 Chee et al. May 1999 A
5908029 Knudson et al. Jun 1999 A
5913854 Maguire et al. Jun 1999 A
5916213 Haissaguerre et al. Jun 1999 A
5916214 Cosio et al. Jun 1999 A
5921924 Avitall Jul 1999 A
5921982 Lesh et al. Jul 1999 A
5925045 Reimels et al. Jul 1999 A
5927284 Borst et al. Jul 1999 A
5928191 Houser et al. Jul 1999 A
5931810 Grabek Aug 1999 A
5931848 Saadat Aug 1999 A
5935123 Edwards et al. Aug 1999 A
5944715 Goble et al. Aug 1999 A
5954661 Greenspon et al. Sep 1999 A
5957919 Laufer Sep 1999 A
5971980 Sherman Oct 1999 A
5971983 Lesh Oct 1999 A
5980516 Mulier et al. Nov 1999 A
5989248 Tu et al. Nov 1999 A
5993412 Deily et al. Nov 1999 A
5993447 Blewett et al. Nov 1999 A
6004269 Crowley et al. Dec 1999 A
6004316 Laufer Dec 1999 A
6004319 Goble et al. Dec 1999 A
6007499 Martin et al. Dec 1999 A
6010500 Sherman et al. Jan 2000 A
6012457 Lesh Jan 2000 A
6015391 Rishton et al. Jan 2000 A
6016811 Knopp et al. Jan 2000 A
6018676 Davis et al. Jan 2000 A
6019757 Scheldrup Feb 2000 A
6024733 Eggers et al. Feb 2000 A
6030381 Jones et al. Feb 2000 A
6036687 Laufer et al. Mar 2000 A
6042556 Beach et al. Mar 2000 A
6048333 Lennox et al. Apr 2000 A
6056744 Edwards May 2000 A
6056745 Panescu et al. May 2000 A
6056746 Goble May 2000 A
6056747 Saadat et al. May 2000 A
6063081 Mulier May 2000 A
6066139 Ryan et al. May 2000 A
6068653 LaFontaine May 2000 A
6071279 Whayne et al. Jun 2000 A
6083237 Huitema et al. Jul 2000 A
6086585 Hovda et al. Jul 2000 A
6088894 Oakley Jul 2000 A
6091995 Ingle et al. Jul 2000 A
6096037 Mulier Aug 2000 A
6113592 Taylor Sep 2000 A
6113596 Hooven et al. Sep 2000 A
6117101 Diederich et al. Sep 2000 A
6120496 Whayne et al. Sep 2000 A
6141576 Littmann et al. Oct 2000 A
6142993 Whayne et al. Nov 2000 A
6142994 Swanson et al. Nov 2000 A
6149620 Baker et al. Nov 2000 A
6149646 West et al. Nov 2000 A
6152920 Thompson et al. Nov 2000 A
6161543 Cox et al. Dec 2000 A
6165174 Jacobs et al. Dec 2000 A
6190384 Ouchi Feb 2001 B1
6193716 Shannon, Jr. Feb 2001 B1
6210406 Webster Apr 2001 B1
6210410 Farin et al. Apr 2001 B1
6210411 Hofmann et al. Apr 2001 B1
6212426 Swanson Apr 2001 B1
6216704 Ingle et al. Apr 2001 B1
6217528 Koblish et al. Apr 2001 B1
6217576 Tu et al. Apr 2001 B1
6224592 Eggers et al. May 2001 B1
6231518 Grabek et al. May 2001 B1
6231591 Desai May 2001 B1
6235020 Cheng et al. May 2001 B1
6235024 Tu May 2001 B1
6237605 Vaska et al. May 2001 B1
6238347 Nix et al. May 2001 B1
6238387 Miller, III May 2001 B1
6238393 Mulier May 2001 B1
6245061 Panescu et al. Jun 2001 B1
6245064 Lesh et al. Jun 2001 B1
6245065 Panescu et al. Jun 2001 B1
6251092 Qin et al. Jun 2001 B1
6251110 Wampler Jun 2001 B1
6251128 Knopp et al. Jun 2001 B1
6258087 Edwards et al. Jul 2001 B1
6264650 Hovda et al. Jul 2001 B1
6266551 Osadchy et al. Jul 2001 B1
6270471 Hechel et al. Aug 2001 B1
6283988 Laufer et al. Sep 2001 B1
6283989 Laufer et al. Sep 2001 B1
6293943 Panescu et al. Sep 2001 B1
6296619 Brisken et al. Oct 2001 B1
6299633 Laufer Oct 2001 B1
6302880 Schaer Oct 2001 B1
6311692 Vaska et al. Nov 2001 B1
6312383 Lizzi et al. Nov 2001 B1
6314962 Vaska et al. Nov 2001 B1
6314963 Vaska et al. Nov 2001 B1
6322559 Daulton et al. Nov 2001 B1
6325797 Stewart et al. Dec 2001 B1
6328735 Curley et al. Dec 2001 B1
6328736 Mulier Dec 2001 B1
6332881 Carner et al. Dec 2001 B1
6352533 Ellman et al. Mar 2002 B1
6358248 Mulier Mar 2002 B1
6361531 Hissong Mar 2002 B1
6364876 Erb et al. Apr 2002 B1
6368275 Sliwa et al. Apr 2002 B1
6371955 Fuimaono et al. Apr 2002 B1
6371956 Wilson et al. Apr 2002 B1
6383151 Diederich et al. May 2002 B1
6385472 Hall et al. May 2002 B1
6398792 O'Connor Jun 2002 B1
6409722 Hoey Jun 2002 B1
6413254 Hissong et al. Jul 2002 B1
6416509 Goble et al. Jul 2002 B1
6419648 Vitek et al. Jul 2002 B1
6425867 Vaezy et al. Jul 2002 B1
6430426 Avitall Aug 2002 B2
6440130 Mulier Aug 2002 B1
6443952 Mulier Sep 2002 B1
6447507 Bednarek et al. Sep 2002 B1
6461314 Pant et al. Oct 2002 B1
6461356 Patterson Oct 2002 B1
6464700 Koblish et al. Oct 2002 B1
6471697 Lesh Oct 2002 B1
6471698 Edwards et al. Oct 2002 B1
6474340 Vaska et al. Nov 2002 B1
6475216 Mulier et al. Nov 2002 B2
6477396 Mest et al. Nov 2002 B1
6478793 Cosman et al. Nov 2002 B1
6484727 Vaska et al. Nov 2002 B1
6488678 Sherman Dec 2002 B2
6488680 Francischelli Dec 2002 B1
6497704 Ein-Gal Dec 2002 B2
6502575 Jacobs et al. Jan 2003 B1
6508815 Strul et al. Jan 2003 B1
6514250 Jahns Feb 2003 B1
6517536 Hooven et al. Feb 2003 B2
6527767 Wang et al. Mar 2003 B2
6537248 Mulier Mar 2003 B2
6558382 Jahns May 2003 B2
6558385 McClurken et al. May 2003 B1
6575969 Rittman, III et al. Jun 2003 B1
6579288 Swanson et al. Jun 2003 B1
6584360 Francischelli Jun 2003 B2
6585732 Mulier Jul 2003 B2
6602248 Sharps et al. Aug 2003 B1
6603988 Dowlatshahi Aug 2003 B2
6605084 Acker et al. Aug 2003 B2
6610055 Swanson et al. Aug 2003 B1
6610060 Mulier Aug 2003 B2
6613048 Mulier Sep 2003 B2
6635034 Cosmescu Oct 2003 B1
6645199 Jenkins et al. Nov 2003 B1
6645202 Pless et al. Nov 2003 B1
6648883 Francischelli Nov 2003 B2
6656174 Hegde et al. Dec 2003 B1
6656175 Francischelli Dec 2003 B2
6663627 Francischelli Dec 2003 B2
6666862 Jain et al. Dec 2003 B2
6679882 Kornerup Jan 2004 B1
6682501 Nelson Jan 2004 B1
6689131 McClurken Feb 2004 B2
6692450 Coleman Feb 2004 B1
6699240 Francischelli Mar 2004 B2
6702810 McClurken et al. Mar 2004 B2
6702811 Stewart et al. Mar 2004 B2
6706038 Francischelli Mar 2004 B2
6706039 Mulier Mar 2004 B2
6716211 Mulier Apr 2004 B2
6736810 Hoey May 2004 B2
6755827 Mulier Jun 2004 B2
6764487 Mulier Jul 2004 B2
6766202 Underwood et al. Jul 2004 B2
6766817 da Silva Jul 2004 B2
6773433 Stewart et al. Aug 2004 B2
6775575 Bommannan et al. Aug 2004 B2
6776780 Mulier Aug 2004 B2
6786906 Cobb Sep 2004 B1
6807968 Francischelli Oct 2004 B2
6827713 Bek et al. Dec 2004 B2
6827715 Francischelli Dec 2004 B2
6832996 Woloszko et al. Dec 2004 B2
6849073 Hoey Feb 2005 B2
6858028 Mulier Feb 2005 B2
6887238 Jahns May 2005 B2
6899711 Stewart et al. May 2005 B2
6911019 Mulier Jun 2005 B2
6915806 Pacek et al. Jul 2005 B2
6916318 Francischelli Jul 2005 B2
6918404 Dias da Silva Jul 2005 B2
6936046 Hissong Aug 2005 B2
6942661 Swanson Sep 2005 B2
6949097 Stewart et al. Sep 2005 B2
6949098 Mulier Sep 2005 B2
6953461 McClurken et al. Oct 2005 B2
6960205 Jahns Nov 2005 B2
6962589 Mulier Nov 2005 B2
7066586 da Silva Jun 2006 B2
7104990 Jenkins et al. Sep 2006 B2
7156845 Mulier et al. Jan 2007 B2
7166106 Bartel et al. Jan 2007 B2
7207471 Heinrich et al. Apr 2007 B2
7232440 Dumbauld et al. Jun 2007 B2
7247155 Hoey et al. Jul 2007 B2
7252665 Starkebaum et al. Aug 2007 B2
7261711 Mulier et al. Aug 2007 B2
7309325 Mulier et al. Dec 2007 B2
7311708 McClurken Dec 2007 B2
7322974 Swoyer et al. Jan 2008 B2
7361175 Suslov Apr 2008 B2
7364579 Mulier et al. Apr 2008 B2
7455669 Swanson Nov 2008 B2
7537595 McClurken May 2009 B2
7571729 Saadat et al. Aug 2009 B2
7604635 McClurken et al. Oct 2009 B2
7608072 Swanson Oct 2009 B2
7645277 McClurken et al. Jan 2010 B2
7651494 McClurken et al. Jan 2010 B2
7691050 Gellman et al. Apr 2010 B2
7736361 Palanker Jun 2010 B2
7811282 McClurken Oct 2010 B2
7815634 McClurken et al. Oct 2010 B2
7819861 Auge et al. Oct 2010 B2
7909820 Lipson Mar 2011 B2
7942872 Ein-Gal May 2011 B2
7976544 McClurken et al. Jul 2011 B2
7993337 Lesh Aug 2011 B2
7997278 Utley et al. Aug 2011 B2
7998140 McClurken et al. Aug 2011 B2
8034071 Scribner et al. Oct 2011 B2
8038670 McClurken Oct 2011 B2
8048070 O'Brien et al. Nov 2011 B2
8083736 McClurken et al. Dec 2011 B2
8105323 Buysse et al. Jan 2012 B2
8172828 Chang et al. May 2012 B2
8177783 Davison et al. May 2012 B2
8216233 McClurken Jul 2012 B2
8348946 McClurken Jan 2013 B2
8361068 McClurken Jan 2013 B2
8388642 Muni et al. Mar 2013 B2
20020045892 Kramer Apr 2002 A1
20020049483 Knowlton Apr 2002 A1
20020062131 Gallo, Sr. May 2002 A1
20020082634 Kammerer et al. Jun 2002 A1
20030014050 Sharkey et al. Jan 2003 A1
20030032954 Carranza et al. Feb 2003 A1
20030045872 Jacobs Mar 2003 A1
20030073993 Ciarrocca Apr 2003 A1
20030144656 Ocel Jul 2003 A1
20030191462 Jacobs Oct 2003 A1
20030204185 Sherman et al. Oct 2003 A1
20030216724 Jahns Nov 2003 A1
20040015106 Coleman Jan 2004 A1
20040015219 Francischelli Jan 2004 A1
20040024395 Ellman et al. Feb 2004 A1
20040044340 Francischelli Mar 2004 A1
20040049179 Francischelli Mar 2004 A1
20040078069 Francischelli Apr 2004 A1
20040082948 Stewart et al. Apr 2004 A1
20040087940 Jahns May 2004 A1
20040092926 Hoey May 2004 A1
20040111136 Sharkey et al. Jun 2004 A1
20040111137 Sharkey et al. Jun 2004 A1
20040116923 Desinger Jun 2004 A1
20040138621 Jahns Jul 2004 A1
20040138656 Francischelli Jul 2004 A1
20040143260 Francischelli Jul 2004 A1
20040186465 Francischelli Sep 2004 A1
20040215183 Hoey Oct 2004 A1
20040220560 Briscoe Nov 2004 A1
20040236322 Mulier Nov 2004 A1
20040267326 Ocel Dec 2004 A1
20050010095 Stewart et al. Jan 2005 A1
20050033280 Francischelli Feb 2005 A1
20050059966 McClurken et al. Mar 2005 A1
20050090815 Francischelli Apr 2005 A1
20050090816 McClurken et al. Apr 2005 A1
20050143729 Francischelli Jun 2005 A1
20050165392 Francischelli Jul 2005 A1
20050171525 Rioux Aug 2005 A1
20050209564 Bonner Sep 2005 A1
20050267454 Hissong Dec 2005 A1
20060009756 Francischelli Jan 2006 A1
20060009759 Christian Jan 2006 A1
20060064085 Schechter et al. Mar 2006 A1
20060106375 Werneth et al. May 2006 A1
20070049920 McClurken et al. Mar 2007 A1
20070093808 Mulier et al. Apr 2007 A1
20070118114 Miller et al. May 2007 A1
20070149965 Gallo, Jr. et al. Jun 2007 A1
20070208332 Mulier et al. Sep 2007 A1
20080004656 Livneh Jan 2008 A1
20080015563 Hoey et al. Jan 2008 A1
20080058796 O'Brien et al. Mar 2008 A1
20080071270 Desinger et al. Mar 2008 A1
20080103494 Rioux May 2008 A1
20080207028 Schutz Aug 2008 A1
20080221567 Sixto et al. Sep 2008 A1
20080262489 Steinke Oct 2008 A1
20090054892 Rioux et al. Feb 2009 A1
20090177192 Rioux et al. Jul 2009 A1
20090264879 McClurken et al. Oct 2009 A1
20090270856 Saadat et al. Oct 2009 A1
20090306655 Stangenes et al. Dec 2009 A1
20100069904 Cunningham Mar 2010 A1
20100100095 McClurken et al. Apr 2010 A1
20100160906 Jarrard Jun 2010 A1
20100168743 Stone et al. Jul 2010 A1
20100204560 Salahieh et al. Aug 2010 A1
20100241178 Tilson et al. Sep 2010 A1
20100312259 Houser et al. Dec 2010 A1
20100331883 Schmitz et al. Dec 2010 A1
20110028965 McClurken Feb 2011 A1
20110137298 Nguyen et al. Jun 2011 A1
20110178515 Bloom et al. Jul 2011 A1
20110196367 Gallo Aug 2011 A1
20110295249 Bloom et al. Dec 2011 A1
20110319889 Conley et al. Dec 2011 A1
20120004657 Conley et al. Jan 2012 A1
20120071712 Manwaring et al. Mar 2012 A1
20120095461 Herscher et al. Apr 2012 A1
20120101496 Mcclurken et al. Apr 2012 A1
20120116397 Rencher et al. May 2012 A1
20120143293 Mauch et al. Jun 2012 A1
20120150165 Conley et al. Jun 2012 A1
20120157989 Stone et al. Jun 2012 A1
20120184983 Chang et al. Jul 2012 A1
20120191084 Davison et al. Jul 2012 A1
20120253343 McClurken et al. Oct 2012 A1
Foreign Referenced Citations (2)
Number Date Country
WO9604955 Feb 1996 WO
WO2010141417 Dec 2010 WO
Non-Patent Literature Citations (4)
Entry
Salameh, F., et al., “An animal model study to clarify and investigate endoscopic tissue coagulation by using new monopolar device,” Gastrointestinal Endoscopy 59:107-112, American Society for Gastrointestinal Endoscopy (2004).
Palanker, D. V., et al., “Electrosurgery with Cellular Precision,” IEEE Transactions on Biomedical Engineering 55:838-841, IEEE (2008).
Barrx Brochure, “HALO Systems: Advanced Ablation Technology for Treating Barrett's Esophagus,” Barrx Medical Incorporated (2008), 8 pages.
PCT International Search Report and Written Opinion dated Mar. 22, 2013.
Related Publications (1)
Number Date Country
20130085493 A1 Apr 2013 US